News

Vicks Action 500 Extra : P&G Stops the Sale after the Ban

The manufacture and sale of Vicks Action 500 Extra have been stopped with immediate effect.
Procter and Gamble (P&G) has discontinued the manufacture and sale of its Famous brand �Vicks Action 500 Extra’ with immediate effect after the government banned fixed dose combination drugs.

“The Government of India has prohibited the manufacture for sale, sale and distribution of fixed dose combination drugs (Paracetamol + Phenylephrine + Caffeine) with immediate effect. Our product ‘Vicks Action 500 Extra’ has the same fixed dose combination and is covered under the notification. We have discontinued the manufacture and sale of all SKUs of ‘Vicks Action 500 Extra with immediate effect.” Pfizer said in a BSE filing.

The Health Ministry has banned 344 ‘Fixed Dose Combination’ (FDC) drugs, leading to an immediate suspension of the manufacturing and sale of some popular medicines in India.

Fixed-dose combination drugs are when a pharmaceutical combines two or more active drugs in a fixed ratio into a single dosage.

According to the notification, the matter has been examined by an expert committee appointed by the Central government.

“On the basis of recommendations of the said expert committee, the Central government is satisfied that it is necessary and expedient in public interest to regulate by way of prohibition of manufacture for sale, sale and distribution for human use of the said drugs in the country,” the notification said.

The 344 banned drugs include the fixed dose combination of Chlopheniramine Maleate and Codeine syrup sold under the popular cough syrup brand Corex.

Following the government ban, pharmaceutical major Pfizer has discontinued manufacture and sale of Corex with immediate effect.

Nisha Johnson

Recent Posts

Fabrinet Announces Third Quarter Fiscal Year 2024 Financial Results

Exceeds Guidance Ranges with Record Revenue and Net Income Per Share BANGKOK--(BUSINESS WIRE)--Fabrinet (NYSE: FN),…

47 mins ago

South Korea Data Center Market Investment Analysis Report 2024-2029: Opportunities in IT, Electrical, Mechanical Infrastructure, General Construction, and Tier Standards – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "South Korea Data Center Market - Investment Analysis & Growth Opportunities 2024-2029" report…

4 hours ago

Revitalized “Marco Polo” Opera Celebrates Sino-Italian Ties at Guangzhou Opera House

GUANGZHOU, China--(BUSINESS WIRE)--On May 3rd and 4th, the Guangzhou Opera House welcomed nearly 200 international…

5 hours ago

BrainChip Earns Australian Patent for Improved Spiking Neural Network

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--BrainChip Holdings Ltd (ASX: BRN, OTCQX: BRCHF, ADR: BCHPY), the world’s first…

5 hours ago

NetApp Appoints Market Growth and Revenue Operations Leader, Dallas Olson to Chief Commercial Officer Role

SAN JOSE, Calif.--(BUSINESS WIRE)--NetApp (NASDAQ: NTAP), the intelligent data infrastructure company, today announced Dallas Olson…

6 hours ago

Biocytogen Enters Into Evaluation and Potential Licensing Agreement With BioCopy For TCR-mimic Antibodies

BEIJING--(BUSINESS WIRE)--#Antibody--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotechnology company focused on…

7 hours ago